New York City, NY -- (SBWIRE) -- 01/07/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: FANUC CORP UNSP ADR (OTCMKTS:FANUY), Air Liquide (ADR) (OTCMKTS:AIQUY), ARCAM AB ORD (OTCMKTS:AMAVF), Advanced Cell Technology, Inc. (OTCMKTS:ACTC)
FANUC CORP UNSP ADR (OTCMKTS:FANUY) declined -2.56%, trading on 105,626 shares, to end the trade at $29.73. The stock changed hands in a range of $29.49 to $29.79, bringing its market capitalization to about $43.48 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $23.59 and was moved to the maximum level of $31.70.
Has FANUY Found The Bottom And Ready To Gain Momentum? Find Out Here
Air Liquide (ADR) (OTCMKTS:AIQUY) declined -2.80%, to complete the trading session at $26.77, with a total volume of 91,499 shares. The stock, on average, trades on a volume of 30,812 shares. It floated in a range of $26.68 to $27.24 during the last trading session, with a beta value of 1.10. Its market capitalization now moved to about $43.06 billion. In the past 52 weeks, the share price has not declined below $23.56 and above $28.75. Air Liquide SA is a France-based company engaged in the production of oxygen, nitrogen, hydrogen and other industrial and medical gases. The Company divides its activities between Gas and Services and Engineering and Construction. Gas and Services activities are divided by customer segments.
Why Should Investors Buy AIQUY After the Recent Fall? Just Go Here and Find Out
ARCAM AB ORD (OTCMKTS:AMAVF) recorded a fall of -2.86% and was in a range of $135.00-$142.98 before closing at $136.00. The stock completed the day with a total volume of 8,036 shares, versus an average volume of 13,134 shares. The share price hit its 52-week low of $22.00 and $171.98 was the best price.
Will AMAVF Get Buyers Even After The Recent Rally? Find Out Here
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) declined -3.08% yesterday, bringing its market capitalization around $153.33 million. The share price, after opening at $0.06, made a high of $0.06 and hovered above $0.06 to end the day at $0.0598. The total number of shares that changed hands during the session was 7.43 million shares, as compared to average trading volume of 5.10 million shares. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Will ACTC Bounce Back After yesterday’s Sharp Sell off? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)